Moxifloxacin (400mg)
Moxiford 400 mg Tablet is used in the treatment of bacterial infections. It is also used in infections of urinary tract, tonsils, sinus, nose, throat, female genital organ, skin & soft tissues and lungs (pneumonia).
1 Strip of 5 Tablet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Moxiford 400 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Moxiford 400 mg Tablet is an antibiotic. It works by stopping the action of a bacterial enzyme called DNA-gyrase. This prevents the bacterial cells from dividing and repairing, thereby killing them.
Related Warnings
It is generally safe to consume alcohol with Moxiford 400 mg Tablet.
Moxiford 400 mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Moxiford 400 mg Tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
Do not drive unless you are feeling well.
Moxiford 400 mg Tablet may make you feel dizzy or light-headed, you may experience a sudden, transient loss of vision, or you may faint for a short period. This may affect your driving ability.
Moxiford 400 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Moxiford 400 mg Tablet is recommended.
However, inform your doctor if you have any underlying kidney disease.
Moxiford 400 mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Moxiford 400 mg Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Moxiford 400 mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
